PFS24 as a prognostic milestone in patients with newly diagnosed primary CNS lymphoma.
Saved in:
| Title: | PFS24 as a prognostic milestone in patients with newly diagnosed primary CNS lymphoma. |
|---|---|
| Authors: | Zeremski, Vanja1 (AUTHOR) vanja.zeremski@med.ovgu.de, Haage, Tobias R.1 (AUTHOR), Witte, Hanno M.2 (AUTHOR), Adolph, Louisa3 (AUTHOR), Beer, Sina A.4 (AUTHOR), Behre, Gerhard5 (AUTHOR), Jacobs, Benedikt6 (AUTHOR), Kahl, Christoph7,8 (AUTHOR), Lalayanni, Chrysavgi9 (AUTHOR), Panse, Jens10,11 (AUTHOR), Papageorgiou, Sotirios12 (AUTHOR), Siakantaris, Marina P.13 (AUTHOR), Schneider, Jessica14 (AUTHOR), Schnetzke, Ulf15 (AUTHOR), Schulz, Alexander5 (AUTHOR), Vassilakopoulos, Theodoros P.13 (AUTHOR), Walter, Jeanette10,11 (AUTHOR), Mougiakakos, Dimitrios1 (AUTHOR) |
| Source: | Journal of Hematology & Oncology. 4/24/2025, Vol. 18 Issue 1, p1-4. 4p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 17568722 |
|---|---|
| DOI: | 10.1186/s13045-025-01700-7 |